Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phio Pharmaceuticals

2.17
-0.0400-1.81%
Post-market: 2.210.0400+1.84%18:13 EDT
Volume:97.81K
Turnover:215.71K
Market Cap:10.41M
PE:-0.23
High:2.26
Open:2.25
Low:2.15
Close:2.21
Loading ...

Phio Pharmaceuticals Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Jun

Phio Pharmaceuticals’ PH-762: Promising Clinical Progress and Strategic Potential Drive Buy Rating

TIPRANKS
·
25 Jun

Phio Pharmaceuticals Advances PH-762 Skin Cancer Trial to Fifth Dose Escalation Cohort Following Positive Safety Review

Reuters
·
25 Jun

Phio Pharmaceuticals Announces Positive Interim Results in Phase 1b Clinical Trial of INTASYL Compound PH-762 for Skin Cancer Treatment

Reuters
·
24 Jun

Phio Pharmaceuticals Corp. Files Initial Beneficial Ownership Statement for Lisa C. Carson, VP of Finance and Administration

Reuters
·
19 Jun

Phio Pharmaceuticals Announces Strategic Initiative and Leadership Changes

TIPRANKS
·
12 Jun

Phio Pharmaceuticals Corp - on June 6, Appoints Lisa Carson as Principal Financial Officer - SEC Filing

THOMSON REUTERS
·
12 Jun

Phio Pharmaceuticals Announces Leadership Changes: Robert Infarinato Named VP of Strategic Development, Lisa Carson Appointed VP of Finance and Administration

Reuters
·
12 Jun

Director Robert L. Ferrara Acquires Common Shares of Phio Pharmaceuticals Corp

Reuters
·
12 Jun

Robert J. Bitterman, Chairman, President & CEO, Reports Acquisition of Common Shares in Phio Pharmaceuticals Corp

Reuters
·
11 Jun

Phio Pharmaceuticals Announces Key Management Appointments: Robert Infarinato as VP of Strategic Development, Lisa Carson as VP of Finance and Administration

Reuters
·
06 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle

Reuters
·
06 Jun

Phio Pharmaceuticals: Undervalued Innovator with Promising siRNA Therapy and Strategic Growth Potential

TIPRANKS
·
06 Jun

BUZZ-U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker Barrel

Reuters
·
05 Jun

Phio Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
05 Jun

Phio Pharmaceuticals assumed with a Buy at H.C. Wainwright

TIPRANKS
·
05 Jun

Phio Pharmaceuticals Corp : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $14

THOMSON REUTERS
·
05 Jun

Robert J. Bitterman, Chairman, President & CEO, Acquires Common Shares of Phio Pharmaceuticals Corp

Reuters
·
23 May

Director Robert L. Ferrara Reports Acquisition of Common Shares of Phio Pharmaceuticals Corp

Reuters
·
22 May

Phio Pharmaceuticals Corp. to Participate in Sidoti Micro-Cap Virtual Investor Conference

Reuters
·
19 May